Genscript Biotech Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

DB:G51 Recent Insider Transactions by Companies or Individuals
Date	Value	Name	Entity	Shares	Max Price
04 Oct 24	Sell€55,744	Li Zhu	Individual	35,000	€1.59
02 Oct 24	Sell€105,111	Li Zhu	Individual	64,375	€1.63
11 Apr 24	Sell€119,447	Zhenyu Liu	Individual	79,695	€1.50
11 Apr 24	Sell€22,665	Weihui Shao	Individual	15,122	€1.50
22 Mar 24	Sell€48,248	Li Zhu	Individual	28,094	€1.72
19 Mar 24	Sell€53,605	Li Zhu	Individual	28,869	€1.86
02 Jan 24	Sell€71,268	Jiange Meng	Individual	31,867	€2.24

Insider Trading Volume

Insider Buying: G51 insiders have only sold shares in the past 3 months.

Ownership Breakdown

What is the ownership structure of G51?
Owner Type	Number of Shares	Ownership Percentage
Individual Insiders	4,232,413	0.197%
Institutions	375,116,850	17.5%
Private Companies	800,637,123	37.4%
General Public	963,083,597	44.9%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.

Top Shareholders

Top 25 shareholders own 52.34% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
37.3%	GenScript Corporation	799,999,123	€960.4m	0%	no data
2.39%	The Vanguard Group, Inc.	51,162,730	€61.4m	0.37%	no data
1.76%	BlackRock, Inc.	37,648,228	€45.2m	1.69%	no data
1.66%	HuaAn Fund Management Company Ltd.	35,544,000	€42.7m	0%	0.18%
1.51%	GF Fund Management Co., Ltd.	32,336,000	€38.8m	0%	0.08%
1.03%	Bosera Asset Management Co., Ltd.	22,064,000	€26.5m	0%	0.12%
1.02%	Zhong Ou Fund Management Co., Ltd	21,808,068	€26.2m	0%	0.11%
0.97%	Harvest Fund Management Co. Ltd.	20,872,000	€25.1m	0%	0.06%
0.56%	AEGON-Industrial Fund Management Co. Ltd.	12,054,000	€14.5m	0%	0.08%
0.51%	Penghua Fund Management Co., Ltd.	10,842,000	€13.0m	0%	0.08%
0.42%	China Asset Management Co. Ltd.	8,985,393	€10.8m	-0.06%	0.01%
0.4%	Hillhouse Investment Management, Ltd.	8,578,000	€10.3m	0%	0.1%
0.33%	Huatai-PineBridge Fund Management Co., Ltd.	7,086,590	€8.5m	0%	0.02%
0.3%	Bank of China Investment Management Co., Ltd.	6,364,000	€7.6m	0%	0.18%
0.28%	Bank of Communications Schroder Fund Management Co., Ltd.	6,081,484	€7.3m	0%	0.06%
0.27%	Caisse de dépôt et placement du Québec	5,785,814	€6.9m	0%	0.01%
0.25%	China Southern Asset Management Co., Ltd.	5,454,000	€6.5m	0%	0.02%
0.25%	Geode Capital Management, LLC	5,334,014	€6.4m	1.23%	no data
0.25%	Tianhong Asset Management Co., Ltd.	5,260,000	€6.3m	0%	0.03%
0.18%	UBS Asset Management AG	3,779,106	€4.5m	41.2%	no data
0.16%	E Fund Management Co., Ltd.	3,470,000	€4.2m	0%	no data
0.15%	Fullgoal Fund Management Co. Ltd.	3,110,000	€3.7m	0%	0.01%
0.14%	Huashang Fund Management Company Ltd.	2,901,659	€3.5m	0%	0.05%
0.12%	Charles Schwab Investment Management, Inc.	2,615,105	€3.1m	0%	no data
0.12%	China Merchants Fund Management Company Ltd.	2,606,000	€3.1m	0%	0.01%

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2024/12/20 13:43
End of Day Share Price	2024/12/20 00:00
Earnings	2024/06/30
Annual Earnings	2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Genscript Biotech Corporation is covered by 21 analysts. 11 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

Analyst	Institution
Linda Lu	BOCI Research Ltd.
Jin Zhang	China International Capital Corporation Limited
Yue-Kwong Lui	China Renaissance Securities